skip to main content
Close Icon We use cookies to improve your website experience.  To learn about our use of cookies and how you can manage your cookie settings, please see our Cookie Policy.  By continuing to use the website, you consent to our use of cookies.
Global Search Configuration
  • Close Icon

Refine Results

Clear All


Show More


Show More

Show More


Show More

Show More

7 Total results for product and free and sample content found

Datamonitor Healthcare: 医療用医薬品の市場調査レポート, Biom...

2019 Q3 Outlook Webinar

By Hardik Patel 15 Jul 2019

Informa Pharma Intelligence presents an essential, free session during which industry analysts present their data-driven views about what to expect during the third quarter of 2019. 

Topic immuno-oncology infectious-diseases

Biomedtracker: 開発中医薬品をFDA承認確率で評価, Datamonitor...

December 2018 National Influenza Week

10 Apr 2019

3 – 9 December is National Influenza Vaccination Week, a national awareness week focused on highlighting the importance of influenza vaccination. In this free KOL Insight Interview excerpt from Datamonitor Healthcare, read what key opinion leaders from the UK and US in Infectious Diseases have to say about current efforts to combat influenza with seasonal influenza vaccines:

Topic influenza-virus infectious-diseases

Horizons in HIV Drug Development – What’s Past is Prologue

10 Apr 2019

While AIDS therapy was once confined to palliative care, clinical progress in the wake of the landmark 1987 approval of zidovudine has seen HIV demoted to a chronic but manageable infection. Following the initial fledgling steps and missteps, the mid-1990s saw the introduction of the now-familiar three-drug combination regimens that raised expectations for a pharmaceutical solution to the epidemic.

Topic Infectious diseases

Datamonitor Healthcare

Datamonitor Healthcare Podcast 16 March 2018

By Jack Allen 11 May 2018

Zach McLellan, Jack Allen, and guest analysts Louisa Joseph and Michael Haydock discuss current events in the healthcare space in the Datamonitor Healthcare Analyst Podcast, including results for Gilead's new HIV flagship product; Biktarvy, and the US approval of the HIV drug Trogarzo, the first for salvage patients.

Topic clinical-trials infectious-diseases


Forge Therapeutics Excites Big Guns In Antibiotic World

20 Dec 2017

Forge Therapeutics is aiming to have developed a novel class of antibiotic to treat Gram-negative superbugs.

Topic infectious-diseases


How J&J Scientist Koul Hopes To Reboot R&D At India’s IMTECH

28 Nov 2017

Topic infectious-diseases


WHO Publishes List Of Pathogen Threats To Rouse Drug Developers

02 Mar 2017

The World Health Organisation has released a list of 12 bacteria it says pose the greatest threat to human health as a way of urging governments and the drug development industry to incentivize and launch an R&D response against the increasing global issue of antibiotic resistance.





電話:+81 (0)3 6273 4260